Updates on the Novel Coronavirus (COVID-19)
Stanford Medicine and the Byers Eye Institute are closely monitoring the outbreak of the novel coronavirus (COVID-19). Our top priority is the safety of our patients, our employees, and our community.
We are continuing to see patients and accept referrals from the community; depending on urgency we may have providers contact patients by phone or video to triage their care appropriately.
University and health system leaders are working closely with government and public health agencies and continue to follow guidelines from the U.S. Department of State, the Centers for Disease Control and Prevention, and the World Health Organization.
Coming in for an appointment?
Rest assured, we have amplified our already-intensive cleaning and disinfecting practices throughout all of our facilities and are screening all patients and visitors.
Your appointment reminder, whether you receive it by phone, text, myhealth message or email, will remind you to call ahead if you are experiencing symptoms (fever, cough, shortness of breath, travel to a highly affected country, or exposure to a known coronavirus patient). Even if you do not have an existing appointment, if you are experiencing symptoms of COVID-19, do not come to the eye clinic unless you are having urgent or emergent eye care issues.
When you arrive
We are actively screening all patients and visitors at our facilities. Please arrive early to your appointment time to allow time for these screening protocols. When you arrive for your appointment, look for signs that will direct you where to go. We will ask about your symptoms and travel history, including if you have traveled to impacted countries. Only 0-1 accompanying and asymptomatic persons can join a patient for their visit in the building. To minimize the risk of exposure for all, ANY person who presents with a positive response to the screening questions will be placed in a dedicated isolated space.
To view updates from Stanford Medicine, visit their COVID-19 site for the latest information and developments about COVID-19.